Trade AbbVie ^ABBV

Top Biotech Stocks To Watch Now - October 10th - Markets Daily

American Hospital Association Sues Over 340B Pilot Program Invol

Oak Grove Capital LLC Buys 17,000 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by Wedmont Private Capital

AbbVie Inc. $ABBV Shares Sold by Davidson Trust Co.

Capital Planning LLC Sells 7,500 Shares of AbbVie Inc. $ABBV

Sound Income Strategies LLC Buys 2,040 Shares of AbbVie Inc. $ABBV - Daily Political

Mirador Capital Partners LP Buys 2,072 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Stock Price Up 1.4% on Analyst Upgrade

Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look

Treasury Bills or Dividend Stocks? The Retirement Income Math May Surprise You

AbbVie (NYSE:ABBV) Shares Climb 1.4% After Analyst Upgrade - Daily Political

Equities Research Analysts' Updated EPS Estimates for October 9th (ABBV, ALAB, ANGO, APA, AVO, CBOE, COST, CRE, CTSH, CVNA) - Stock Observer

AbbVie's (ABBV) Buy Rating Reiterated at Guggenheim

AbbVie (ABBV) Outgrew Humira's Collapse. Is its Forward P/E Fair for What Comes Next?

Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

AbbVie Inc. $ABBV Shares Purchased by Mn Services Vermogensbeheer B.V.

GAMMA Investing LLC Purchases 7,058 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stock Sold by Bell Asset Management Ltd

AbbVie Inc. $ABBV Position Increased by Farther Finance Advisors LLC - Zolmax

14,020 AbbVie Inc. $ABBV Shares Acquired by Sapient Capital LLC

AbbVie Inc. $ABBV Shares Bought by Meadowbrook Wealth Management LLC - Markets Daily

AbbVie Inc. $ABBV Shares Acquired by Meadowbrook Wealth Management LLC - Zolmax

AbbVie Inc. $ABBV Stock Acquired by Farther Finance Advisors LLC

AbbVie (NYSE:ABBV) Stock Gets Price Target Bump from JPMorgan Chase & Co.

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock - Zolmax

AbbVie Inc. $ABBV Stock Sold by Hamlin Capital Management LLC

AbbVie Inc. $ABBV Stock Acquired by Artemis Investment Management LLP

AbbVie Inc. $ABBV Stock Position Increased by Toth Financial Advisory Corp - Stock Observer

AbbVie (NYSE:ABBV) Price Target Raised to $290.00

Biotech Stocks At 52-Week Highs - ABBV On FDA Designations, HSTM, OGN

8,817 AbbVie Inc. $ABBV Shares Bought by Congress Asset Management Co.

AbbVie (NYSE:ABBV) Issues Q3 2026 Earnings Guidance - Stock Observer

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Scotiabank Analyst Says

Biotech Stocks To Keep An Eye On - October 6th - Markets Daily

3 'Strong Buy' Dividend Aristocrat Stocks on Analysts' Watch List

Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?

AbbVie (NYSE:ABBV) Stock Price Up 1.8% Following Analyst Upgrade

Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets

2,008 AbbVie Inc. $ABBV Shares Sold by Canandaigua National Bank & Trust Co. - Stock Observer

5,659 AbbVie Inc. $ABBV Shares Sold by MRA Advisory Group

American National Bank & Trust Reduces Stake in AbbVie Inc. $ABBV

AbbVie's Temab-A Earns FDA Breakthrough Therapy Designations In CRC, NSCLC;Stock Up

AbbVie's Telisotuzumab Adizutecan Secures Dual FDA Breakthrough Therapy Designations

AbbVie (NYSE:ABBV) Hits New 12-Month High on Analyst Upgrade - Stock Observer

Genmab (CPSE:GMAB) Posts Two Strong Trial Readouts, Is The Valuation Now Too Hard To Ignore?

AbbVie (ABBV) Cut Frontline DLBCL Progression Or Death Risk By 51%

AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?

AbbVie Stocks Edge Higher as Lymphoma Trial Cuts Progression Risk 51%

Forget Bonds: How Retirees Collect $6,650 a Month From Dividends Alone

AbbVie Inc. $ABBV Stock Sold by Hall Laurie J Trustee - Daily Political

Prediction: LLY Has Another Massive Growth Opportunity Beyond Weight Loss

Abbvie-Genmab Epkinly data signal first-line filing for DLBCL

Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms

Scotiabank Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock

$100,000 in 5 Dividend Kings Will Generate Close to $4,000 Each Year Safely

AbbVie Rewarded Patient Investors but Punished Those Who Bought on Good News

AbbVie (NYSE:ABBV) Releases Q3 2026 Earnings Guidance

Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug | Morningstar

Genmab and AbbVie's Epcoritamab Treatment Significantly Reduces Blood Cancer Progression Risk, ETPharma

AbbVie Inc. (ABBV) Stock: Phase 3 Lymphoma Trial Cuts Progression Risk 51%

AbbVie (NYSE:ABBV) Stock Price Up 1.2% - Still a Buy?

Genmab stock surges 11% on positive cancer drug trial data

Park National Corp OH Sells 6,771 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Lowered by Eastern Bank

AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

AbbVie (NYSE:ABBV) Stock Jumps 1.2% - Still a Buy? - Daily Political

AbbVie Inc. $ABBV Stock Position Lessened by MassMutual Private Wealth & Trust FSB

Best Pharmaceutical Stocks To Add to Your Watchlist - October 4th - Stock Observer

Is AbbVie (ABBV) Still Undervalued On FDA Approval And Fresh Pipeline Data?

AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?

Pharmaceutical Stocks To Watch Now - October 3rd - Zolmax

5 High-Yield Dividend Stocks to Buy for October Income with Cash Flow to Spare

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Biotech Stocks To Watch Now - October 2nd - Daily Political

Eli Lilly (LLY) and AbbVie (ABBV) Are Expanding Their Pipelines. Their Valuations Tell Two Different Stories

AbbVie (NYSE:ABBV) Stock Jumps 1.3% - Here's What Happened

How Much Does a 58-Year-Old Need Invested to Replace a $160,000 Salary With Dividends?

CX Institutional Cuts Stock Position in AbbVie Inc. $ABBV - Daily Political

Biotech Stocks To Watch Now - October 2nd - Zolmax

Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease

RINVOQ Drives Continued Skin Repigmentation Through Week 76 In AbbVie Studies

HRSA discloses manufacturers approved for revised 340B rebate pilot

5 Solid Dividend Stocks to Buy Now

AbbVie to Host Third-Quarter 2026 Earnings Conference Call | Morningstar

5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test)

RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)

What Does AbbVie (ABBV) Need To Prove After Its Eczema Drug And AI Update?

AbbVie To Present New Dermatology Data At 2026 EADV Congress

Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson

AbbVie Inc. (ABBV) Stock: Rebounds as Zumilokibart Shows Strong Skin and Itch Improvement Results